| Literature DB >> 17346856 |
Maria Noêmia Martins de Lima1, Caroline Pietá Dias, Juliana Presti Torres, Arethuza Dornelles, Vanessa Athaíde Garcia, Felipe Siciliani Scalco, Marcelo Rewsaat Guimarães, Roberta Cristina Petry, Elke Bromberg, Larissa Constantino, Patricia Budni, Felipe Dal-Pizzol, Nadja Schröder.
Abstract
It is now generally accepted that iron accumulates in the brain during the ageing process. Increasing evidence demonstrate that iron accumulation in selective regions of the brain may generate free radicals, thereby possessing implications for the etiology of neurodegenerative disorders. In a previous study we have reported that aged rats present recognition memory deficits. The aim of the present study was to evaluate the effect of desferoxamine (DFO), an iron chelator agent, on age-induced memory impairment. Aged Wistar rats received intraperitoneal injections of saline or DFO (300mg/kg) for 2 weeks. The animals were submitted to a novel object recognition task 24h after the last injection. DFO-treated rats showed normal recognition memory while the saline group showed long-term recognition memory deficits. The results show that DFO is able to reverse age-induced recognition memory deficits. We also demonstrated that DFO reduced the oxidative damage to proteins in cortex and hippocampus. Thus, the present findings provide the first evidence that iron chelators might prevent age-related memory dysfunction.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17346856 DOI: 10.1016/j.neurobiolaging.2007.02.006
Source DB: PubMed Journal: Neurobiol Aging ISSN: 0197-4580 Impact factor: 4.673